Our results suggested that Th17 cells percentage was lower in DLBCL tumor tissues than in PBMCs or corresponding adjacent benign tissues; accordingly, the level of IL-17A was also lower in tumor tissues than in benign tissues, and the expression of IFN-γ was the opposite. This evidence concerns the gene IL17A and diffuse large B-cell lymphoma.